Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Guideline Harmonization Group Recommendations for Breast Cancer Surveillance in Childhood, Adolescent, and Young Adult Cancer Survivors After Anthracyclines.

JCO oncology practice·2026
Same author

Barriers and facilitators associated with long-term follow-up care for childhood, adolescent, and young adult cancer survivors: a systematic review.

BMC health services research·2025
Same author

Health-care transitions for young people living beyond childhood and adolescent cancer: recommendations from the EU-CAYAS-NET consortium.

The Lancet. Oncology·2025
Same author

Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

European journal of endocrinology·2025
Same author

Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

The Lancet. Oncology·2023
Same author

Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2022

Related Experiment Video

Updated: May 29, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Renal tumours: long-term outcome.

Gill Levitt1

  • 1Department of Oncology/Haematology, Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London, WC1N 3JH, UK. levitg@gosh.nhs.uk

Pediatric Nephrology (Berlin, Germany)
|September 28, 2011
PubMed
Summary

Childhood cancer survivors face long-term health issues from treatments like radiation and chemotherapy. Early recognition of these late adverse effects is crucial for improving outcomes and reducing mortality.

Area of Science:

  • Pediatric Oncology
  • Cancer Survivorship

Background:

  • Childhood cancer incidence is low, with renal tumors accounting for 7% of cases.
  • Multimodality treatment has significantly improved 5-year survival rates to over 80%.

Purpose of the Study:

  • To highlight the critical importance of recognizing and managing late adverse effects of childhood cancer treatment.
  • To emphasize the link between specific treatments and long-term health consequences in survivors.

Main Methods:

  • Review of treatment modalities including surgery, radiotherapy, and chemotherapy.
  • Analysis of common late adverse effects such as secondary malignant neoplasms and cardiac dysfunction.
  • Consideration of genetic predispositions and their interaction with treatment.

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Related Experiment Videos

Last Updated: May 29, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Main Results:

  • Successful cancer treatment leads to significant long-term morbidities and potential premature death.
  • Radiation therapy is linked to tissue damage, impaired growth/function, and secondary cancers.
  • Anthracyclines and cardiac radiation contribute to cardiac dysfunction; genetic factors can worsen renal dysfunction.

Conclusions:

  • Awareness of late treatment consequences is vital for early detection and improved patient outcomes.
  • Understanding a patient's treatment history is essential for managing presenting problems in renal tumor survivors.
  • Proactive monitoring and management of late effects are necessary for enhancing the quality of life for childhood cancer survivors.